Edition:
United Kingdom

AC Immune SA (ACIU.OQ)

ACIU.OQ on NASDAQ Stock Exchange Global Market

11.68USD
5:36pm GMT
Change (% chg)

$-0.11 (-0.93%)
Prev Close
$11.79
Open
$11.80
Day's High
$11.87
Day's Low
$11.68
Volume
3,190
Avg. Vol
26,694
52-wk High
$13.91
52-wk Low
$6.24

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 1.07 -0.154
Jun '17 0.75 -0.216
Mar '17 2.01 -0.166
FY 2016 Dec '16 1.43 -0.124
Sep '16 1.33 -0.169
Jun '16 19.96 0.240
Mar '16 0.49 -0.114
 
*Note: Units in Millions ofSwiss Francs
**Note: Units in Swiss Francs

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 1 7.08 7.08 7.08 --
Quarter Ending Jun-18 1 7.68 7.68 7.68 --
Year Ending Dec-18 3 25.08 25.27 24.87 7.18
Earnings (per share)
Quarter Ending Mar-18 1 -0.10 -0.10 -0.10 --
Quarter Ending Jun-18 1 -0.11 -0.11 -0.11 --
Year Ending Dec-18 3 -0.71 -0.58 -0.85 -1.11
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 83.93 32.90
P/E High - Last 5 Yrs. -- 292.71 45.97
P/E Low - Last 5 Yrs. -- 91.44 24.37
Beta -- 0.90 0.89
Price to Sales (TTM) 113.23 110.72 5.77
Price to Book (MRQ) 5.17 13.56 5.41
Price to Tangible Book (MRQ) 5.17 14.02 6.98
Price to Cash Flow (TTM) -- 71.33 23.42
% Owned Institutions 18.18 12.89 2.22

Dividends

  Company industry sector
Dividend Yield -- 0.31 1.50
Dividend Yield - 5 Year Avg -- 0.26 1.52
Dividend 5 Year Growth Rate -- 1.66 5.21
Payout Ratio(TTM) -- 15.70 43.72

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -96.23 398.33 9.24
Sales (TTM) vs TTM 1 Yr. Ago -87.77 78.63 5.59
Sales - 5 Yr. Growth Rate -- 32.11 10.27
EPS (MRQ) vs Qtr. 1 Yr. Ago -190.05 25.10 19.65
EPS (TTM) vs TTM 1 Yr. Ago -263.41 -- --
EPS - 5 Yr. Growth Rate -- 38.95 10.73
Capital Spending - 5 Yr. Growth Rate -- 40.24 15.19

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.80 2.18
Current Ratio (MRQ) 21.60 5.30 2.97
LT Debt to Equity (MRQ) 0.32 22.82 12.22
Total Debt to Equity (MRQ) 0.32 24.47 16.52
Interest Coverage (TTM) -- -98.78 33.13

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 40.03 54.70
Gross Margin - 5 Yr. Avg. -- 51.06 52.42
EBITD Margin (TTM) -594.80 -- --
EBITD - 5 Yr. Avg -- -572.68 10.86
Operating Margin (TTM) -601.68 -717.10 4.64
Operating Margin - 5 Yr. Avg. -- -594.00 6.26
Pre-Tax Margin (TTM) -645.62 -691.66 5.44
Pre-Tax Margin - 5 Yr. Avg. -- -597.35 6.60
Net Profit Margin (TTM) -645.62 -692.88 1.76
Net Profit Margin - 5 Yr. Avg. -- -600.21 2.91
Effective Tax Rate (TTM) -- 22.57 23.04
Effective Tax Rate - 5 Yr. Avg. -- 18.19 23.96

Efficiency

  Company industry sector
Revenue/Employee (TTM) 84,281 22,602,121 855,667,832
Net Income/Employee (TTM) -544,130 2,968,747 100,655,557
Receivable Turnover (TTM) 8.62 20.14 5.78
Inventory Turnover (TTM) -- 2.36 3.35
Asset Turnover (TTM) 0.05 0.39 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -30.40 -1.05 10.98
Return on Assets - 5 Yr. Avg. -- -0.57 12.37
Return on Investment (TTM) -32.55 1.66 14.43
Return on Investment - 5 Yr. Avg. -- 2.23 16.18
Return on Equity (TTM) -33.72 2.58 16.13
Return on Equity - 5 Yr. Avg. -- 3.13 17.47
  1 Year 3 Year 5 Year
Sales % -40.61 39.04 --
EPS (TTM) % -137.69 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for AC Immune SA

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 21.33%
# of Holders: 28
Total Shares Held: 12,111,344
3 Mo. Net Change: 1,779,291
# New Positions: 9
# Closed Positions: 0
# Increased Positions: 14
# Reduced Positions: 3
# Net Buyers: 11
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.